$TMO

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific provides products and services to customers in pharmaceutical and biotechnology companies, hospitals, clinical diagnostic laboratories, universities, research institutions, government agencies, and environmental, industrial and research settings. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its offerings include research reagents and instruments, analytical and diagnostic products, laboratory supplies, and outsourced drug development, clinical research, clinical trials and commercial manufacturing services. Thermo Fisher sells through a direct sales force, customer-service professionals, e-commerce and third-party distributors, and offers products and services under brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Its business includes both self-manufactured and sourced products, as well as services for pharmaceutical and biotech companies. Thermo Fisher is headquartered in Waltham, Massachusetts.

1
2
0
—
$4.9M
Pettiti Gianluca
67%
See all $TMO insider activity →
Low

Pettiti Gianluca sold $2.9M of TMO

Pettiti Gianluca (President & COO) sold 4,133 shares of THERMO FISHER SCIENTIFIC INC. (TMO) at $701.42 ($2.90M total) across 2 trades on 2026-11-13 under a Rule 10b5-1 trading plan.

Cape EMS firms up strategic life sciences engagement with US-based Thermo Fisher Scientific

Cape EMS Bhd, a Malaysia-based electronics manufacturing company, has finalized a contract with Thermo Fisher Scientific for life sciences projects. The agreement, effective August 20, 2026, spans three years with possible extensions. Cape EMS's subsidiary, iConn Technologies, will support research, development, and production across the US, Europe, and Asia. The deal aligns with Cape EMS's Intelligent Manufacturing Network strategy.

New Methylation Profiling Assay for Liquid Biopsy

mDETECT and Thermo Fisher Scientific launched a research assay for cancer detection via methylation profiling of circulating tumor DNA (ctDNA) in blood samples. The Ion AmpliSeq HD Lung Cancer cfDNA Methylation Assay combines mDETECT's methylation analysis with Thermo Fisher's Ion AmpliSeq HD technology. Biodesix will evaluate the assay for lung cancer diagnostics. The assay is for research use only, not yet for diagnostics.

TMO sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning TMO (THERMO FISHER SCIENTIFIC INC.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.

Recent TMO coverage spans technology, corporate actions and insider activity.

In the last 30 days, TMO insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($4.9M). The most active reporter was Pettiti Gianluca, President & COO, with 2 filings. 67% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving TMO

AlphAI scores every news story that mentions TMO with an AI model for sentiment and relevance, and aggregates insider trades from THERMO FISHER SCIENTIFIC INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TMO

Score

Cape EMS firms up strategic life sciences engagement with US-based Thermo Fisher Scientific

Cape EMS Bhd, a Malaysia-based electronics manufacturing company, has finalized a contract with Thermo Fisher Scientific for life sciences projects. The agreement, effective August 20, 2026, spans three years with possible extensions. Cape EMS's subsidiary, iConn Technologies, will support research, development, and production across the US, Europe, and Asia. The deal aligns with Cape EMS's Intelligent Manufacturing Network strategy.

New Methylation Profiling Assay for Liquid Biopsy

mDETECT and Thermo Fisher Scientific launched a research assay for cancer detection via methylation profiling of circulating tumor DNA (ctDNA) in blood samples. The Ion AmpliSeq HD Lung Cancer cfDNA Methylation Assay combines mDETECT's methylation analysis with Thermo Fisher's Ion AmpliSeq HD technology. Biodesix will evaluate the assay for lung cancer diagnostics. The assay is for research use only, not yet for diagnostics.

Thermo Fisher Introduces Benchtop Spark-OES Analyzer for Routine Metals Quality Control

Thermo Fisher Scientific launched the ARL Spark Companion OES Metal Analyzer, a benchtop system for routine metal composition analysis. The company claims it offers 25-second analysis times and is designed for in-house quality control. The analyzer is targeted at labs needing routine QC without high-end spectrometer capabilities, with applications in foundries, metal processing, and recycling. It complements Thermo Fisher's existing floor-standing systems.

Thermo Fisher Scientific Introduces Value-Priced Thermo Scientific™ AmpSure™ Universal qPCR Master Mixes Without Compromising Performance

Thermo Fisher Scientific launched Thermo Scientific AmpSure Universal SYBR Green and Probe Master Mixes for qPCR, offering value-priced, reliable performance. The mixes are compatible with various instruments and workflows, supporting gene expression analysis, genotyping, and microbe detection. The company aims to help labs balance performance and budget without changing existing workflows. Thermo Fisher Scientific reported annual revenue over $45 billion.

Thermo Fisher Scientific Launches Orbitrap Mass Spectrometers for Isotope Ratio Analysis

Thermo Fisher Scientific launched the Orbitrap Isora and Orbitrap Isora Pro Mass Spectrometers, its first Orbitrap instruments with a dedicated isotope ratio analysis mode. The instruments, paired with the Vanquish Duo UHPLC System and new Isotope Discoverer Software, aim to make molecular-level isotope ratio analysis more accessible to researchers in various fields. According to the company, the workflow simplifies analysis and provides detailed insights into a sample's origin and history.

Related tickers